346 related articles for article (PubMed ID: 33790863)
21. Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis.
Laurent I; Tang S; Astère M; Wang KR; Deng S; Xiao L; Li QF
Endocrine; 2018 Jul; 61(1):28-35. PubMed ID: 29572710
[TBL] [Abstract][Full Text] [Related]
22. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
23. Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy.
Wennlund A
Acta Endocrinol (Copenh); 1986 Sep; 113(1):47-9. PubMed ID: 3766048
[TBL] [Abstract][Full Text] [Related]
24. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
Solter D; Solter M
Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
[TBL] [Abstract][Full Text] [Related]
25. Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.
Brancato D; Scorsone A; Saura G; Ferrara L; Di Noto A; Aiello V; Fleres M; Provenzano V
Endocr Pract; 2014 Jul; 20(7):657-62. PubMed ID: 24449674
[TBL] [Abstract][Full Text] [Related]
26. Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation.
Morelli S; Reboldi G; Moretti S; Menicali E; Avenia N; Puxeddu E
Endocrine; 2016 Jun; 52(3):571-8. PubMed ID: 26537478
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
28. Recent evidence sets therapeutic targets for levothyroxine-treated patients with primary hypothyroidism based on risk of death.
Perros P; Nirantharakumar K; Hegedüs L
Eur J Endocrinol; 2021 Feb; 184(2):C1-C3. PubMed ID: 33306038
[TBL] [Abstract][Full Text] [Related]
29. [Variations in the serum levels of thyroid hormones and TSH after intake of a dose of L-thyroxine in euthyroid subjects and in adequately-treated hypothyroid patients].
Custro N; Scafidi V; Costanzo G; Corsello FP
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1045-52. PubMed ID: 2629824
[TBL] [Abstract][Full Text] [Related]
30. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
Shimon I; Cohen O; Lubetsky A; Olchovsky D
Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
[TBL] [Abstract][Full Text] [Related]
32. Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A 2020 THESIS Questionnaire Survey of Members of the Swedish Endocrine Society.
Planck T; Lantz M; Perros P; Papini E; Attanasio R; Nagy EV; Hegedüs L
Front Endocrinol (Lausanne); 2021; 12():795111. PubMed ID: 34938274
[TBL] [Abstract][Full Text] [Related]
33. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
Kabadi UM; Cech R
J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
[TBL] [Abstract][Full Text] [Related]
34. Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients.
Giusti M; Mortara L; Machello N; Monti E; Pera G; Marenzana M
Drug Res (Stuttg); 2015 Jun; 65(6):332-6. PubMed ID: 25020105
[TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
36. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.
Philippou G; Koutras DA; Piperingos G; Souvatzoglou A; Moulopoulos SD
Clin Endocrinol (Oxf); 1992 Jun; 36(6):573-8. PubMed ID: 1424182
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism.
Trimboli P; Mouly S
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743549
[TBL] [Abstract][Full Text] [Related]
38. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism.
Price DE; O'Malley BP; Northover B; Rosenthal FD
Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141
[TBL] [Abstract][Full Text] [Related]
39. No role for tri-iodothyronine (T3) testing in the assessment of levothyroxine (T4) over-replacement in hypothyroid patients.
Livingston M; Birch K; Guy M; Kane J; Heald AH
Br J Biomed Sci; 2015; 72(4):160-3. PubMed ID: 26738396
[TBL] [Abstract][Full Text] [Related]
40. TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with L-thyroxine alone or in combination with L-triiodothyronine.
Fadeyev VV; Morgunova TB; Sytch JP; Melnichenko GA
Hormones (Athens); 2005; 4(2):101-7. PubMed ID: 16613812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
